The Shoes & Retail Apparel industry players are riding premiumization and digital momentum, but rising costs and promotions test margins. Stocks like NKE, ADDYY, BIRK, CRI and CAL are positioned for ...

Q2 2026 Earnings Call February 22, 2026 5:30 PM ESTCompany ParticipantsAaron Gray - Chief Financial OfficerShawn OBrien ...

Aleksei Sovetkin, explains how his approach of connecting brands with passionate local communities helps companies move past digital noise and build real-world trust with their customers.  As we enter ...

AI rewards clear answers and structured, retrievable content. Learn how to reformat, prioritize, and refine metadata for visibility.

Today, Zacks Equity Research discusses NIKE Inc. NKE, adidas AG ADDYY, Birkenstock Holding plc BIRK, Carter’s, Inc. CRI and ...

With Dear Valentine, a collection of design-forward vacation rentals in NOLA, Melissa Shelton is partnering with decor brands ...

X4 Pharmaceuticals is a BUY, driven by a funded Phase 3 trial, current product pipeline, and a strong cash position extending into 2028. Read XFOR stock update.

In an interview with Travel Daily Media, Phillipa Harrison, CEO, Ras Al Khaimah Tourism Development Authority (RAKTDA) shares ...

Telsey Advisory Group raised its valuation benchmark for Victoria Secret Co Quarterly earnings outpaced consensus ...

Songtrybe Electrifies Grammy Weekend with Star-Studded Launch Party, Ushering in a New Era of Artist Empowerment LOS ...

The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.